Close

Agile Therapeutics (AGRX) Receives CRL from FDA for Twirla for Prevention of Pregnancy

December 22, 2017 7:31 AM EST Send to a Friend
Agile Therapeutics, Inc., (NASDAQ: AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) issued ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login